Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreYour world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreFor government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MORECompanies engaged in any activity within the pharmaceutical industry are required to adhere to a vast array of state licensing requirements. In addition to the challenges these requirements inherently bring, they are also ever changing.
In this webinar, we will outline the most common obstacles that can impede compliance with statutory law and the board regulations. There are both internal and external events that can trigger a licensing requirement.
We will discuss universal challenges that we see amongst pharmaceutical companies. We'll review how best to organize internal corporate information and coordinate processes among various internal departments to continuously remain proactive with internal changes. Additionally, we will discuss the most common changes and associated state required timelines in order to stay compliant with Board requirements.
Liz Updike
Director and Sr. Attorney, State Services, IQVIA